Top Markets
#1 Islamic Coin Islamic Coin +151.47%
#2 DOVU DOVU +48.45%
#3 Black Phoenix Black Phoenix +34.85%
#4 Velvet Velvet +30.94%
#5 Cross Cross +19.36%
#6 Akedo Akedo +17.98%
#7 DoubleZero DoubleZero +14.50%
#8 Not in Employment, Education, or Training Not in Employment, Education, or Training +11.43%
#9 Fake World Assets Fake World Assets +10.49%
#10 Cap Cap +10.24%
Coin of the day
Islamic Coin Islamic Coin
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
Peringkat dalam Saham #41091
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Harga Saham
$0.0202
Terakhir disinkronkan: 2024-11-19
Kapitalisasi Pasar
$44.67K
Perubahan (1 hari)
-0.49%
Perubahan (1 tahun)
0.00%
Negara
IL
Perdagangan Notable Labs, Ltd. (NTBL)

Kategori

Healthcare
Laba untuk Notable Labs, Ltd. (NTBL)
Laba pada Jun 2024 TTM: $-8.99M
Menurut laporan keuangan terbaru dari Notable Labs, Ltd., laba saat ini perusahaan adalah $-8.99M. Pada tahun 2022, perusahaan memperoleh laba sebesar $-14.41M, peningkatan dibandingkan laba tahun 2021 sebesar $-16.05M. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Notable Labs, Ltd. dari 2015 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
2026 (TTM) $-8.99M -20.23%
2023 $-11.26M -21.82%
2022 $-14.41M -10.25%
2021 $-16.05M -33.74%
2020 $-24.23M 24.90%
2019 $-19.40M -5.19%
2018 $-20.46M 101.80%
2017 $-10.14M -36.65%
2016 $-16.00M 7.48%
2015 $-14.89M 0.00%
Laba untuk perusahaan serupa atau pesaing
Perusahaan Laba Perbedaan Laba Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -58,807.85%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -21,810.07%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -33,552.61%
BE